Generic Drugmakers Struggle Despite U.S. Push for Copycats

(Bloomberg) -- Generic drugmakers are being crushed by the very forces that the Trump administration is counting on to drive down prescription costs.

Bloomberg Quint

Add BloombergQuint App to Home screen.